by Bagolie Friedman Injury Lawyers | Oct 13, 2017 | Defective Product Liability
Lariam (generic name: mefloquine hydrochloride) has been linked to serious psychiatric side effects including suicide, aggression and long term mental problems. Lariam is a popular malaria prevention drug prescribed to thousands of U.S. travelers and military... by Bagolie Friedman Injury Lawyers | Oct 13, 2017 | Defective Product Liability
Vioxx (Rofecoxib) is a Cox-2 inhibitor that was approved by the US Food and Drug Administration in 1999 for the treatment of arthritis, osteoarthritis, menstrual pain and for the management of acute pain in adults. Serious concerns have been raised in recent months... by Bagolie Friedman Injury Lawyers | Oct 13, 2017 | Defective Product Liability
Complete Moisture PLUS is an “all-in-one” multi-purpose contact lens solution which is manufactured by Advanced Medical Optics (AMO). The company issued a contact solution recall on May 26, 2007 after an alarmingly high number of reported cases of an... by Bagolie Friedman Injury Lawyers | Oct 13, 2017 | Defective Product Liability
Johnson & Johnson’s Ortho Evra contraceptive patch contains higher levels of a hormone known to cause blood clots than average birth control pills, U.S. regulators warned. The U.S. Food and Drug Administration said on November 10, 2005 that the new label for... by Bagolie Friedman Injury Lawyers | Oct 13, 2017 | Defective Product Liability
The use of Crestor has been linked to Rhabdomyolysis, a serious condition which may cause serious muscular problems and death. Over 104 million Americans have high or dangerously high cholesterol. High cholesterol places people at risk for heart attacks, heart... by Bagolie Friedman Injury Lawyers | Oct 13, 2017 | Defective Product Liability
Johnson & Johnson’s DePuy Spine Unit began selling Charite Artificial Spinal Discs in 2004. This product was supposed to reduce the need for spinal fusion and other serious spinal surgeries. However, the Charite artificial discs have been associated with...
